Eagle Pharmaceuticals Inc (OTCPK:EGRX)
$ 0.5 -0.0102 (-2%) Market Cap: 6.48 Mil Enterprise Value: - PE Ratio: 0 PB Ratio: 0 GF Score: 60/100

Q3 2021 Eagle Pharmaceuticals Inc Earnings Call Transcript

Nov 09, 2021 / 01:30PM GMT
Release Date Price: $51.4 (+0.61%)
Operator

Good morning, everyone. My name is Ashley, and I will be your conference operator today. At this time, I'd like to welcome everyone to Eagle Pharmaceuticals Third Quarter 2021 Financial Results Call. (Operator Instructions) As a reminder, this conference call is being recorded today, November 9, 2021.

It is now my pleasure to turn the floor over to Ms. Lisa Wilson, Investor Relations for Eagle Pharmaceuticals. Please go ahead.

Lisa Wilson

Thank you, Ashley. Welcome to Eagle Pharmaceuticals Third Quarter Earnings Call. This is Lisa Wilson, Investor Relations for Eagle Pharmaceuticals. With me on today's call are Eagle's President and Chief Executive Officer, Scott Tarriff; and Chief Financial Officer, Brian Cahill. This morning, the company issued a press release detailing financial results for the 3 months ended September 30, 2021. This press release and a webcast of this call can be accessed through the Investors section of the Eagle website at eagleus.com.

Before we get started, I would like to remind everyone that any statements made on today's

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot